Claims for Patent: 11,028,448

✉ Email this page to a colleague

Summary for Patent: 11,028,448

Title:	Methods of identifying risk of vascular endothelial growth factor (VEGF) pathway inhibitor-induced hypertension
Abstract:	The disclosure relates to methods of identifying subjects at risk of developing bevacizumab-induced toxicities such as proteinuria and/or hypertension involving measuring nucleic acid or gene mutations in a sample obtained from the subject.
Inventor(s):	Innocenti Federico, Quintanilha Julia, Lin Danyu, Owzar Kouros, Wang Jin
Assignee:
Application Number:	US16932002
Patent Claims:

Details for Patent 11,028,448

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Llc	INTRON A	interferon alfa-2b	For Injection	103132	June 04, 1986	11,028,448	2040-07-17
Merck Sharp & Dohme Llc	INTRON A	interferon alfa-2b	For Injection	103132		11,028,448	2040-07-17
Merck Sharp & Dohme Llc	INTRON A	interferon alfa-2b	Injection	103132		11,028,448	2040-07-17
Aim Immunotech Inc.	ALFERON N INJECTION	interferon alfa-n3 (human leukocyte derived)	Injection	103158	October 10, 1989	11,028,448	2040-07-17
Merck Sharp & Dohme Llc	PEGINTRON	peginterferon alfa-2b	Injection	103949	January 19, 2001	11,028,448	2040-07-17
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.